EP3810807A4 - Verfahren und zusammensetzungen für die analyse von krebsbiomarkern - Google Patents

Verfahren und zusammensetzungen für die analyse von krebsbiomarkern Download PDF

Info

Publication number
EP3810807A4
EP3810807A4 EP18923183.0A EP18923183A EP3810807A4 EP 3810807 A4 EP3810807 A4 EP 3810807A4 EP 18923183 A EP18923183 A EP 18923183A EP 3810807 A4 EP3810807 A4 EP 3810807A4
Authority
EP
European Patent Office
Prior art keywords
compositions
analysis
methods
cancer biomarkers
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18923183.0A
Other languages
English (en)
French (fr)
Other versions
EP3810807A1 (de
Inventor
Brandon STEELMAN
Julia Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clear Gene Inc
Original Assignee
Clear Gene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Gene Inc filed Critical Clear Gene Inc
Publication of EP3810807A1 publication Critical patent/EP3810807A1/de
Publication of EP3810807A4 publication Critical patent/EP3810807A4/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP18923183.0A 2018-06-22 2018-06-22 Verfahren und zusammensetzungen für die analyse von krebsbiomarkern Pending EP3810807A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2018/039163 WO2019245587A1 (en) 2018-06-22 2018-06-22 Methods and compositions for the analysis of cancer biomarkers

Publications (2)

Publication Number Publication Date
EP3810807A1 EP3810807A1 (de) 2021-04-28
EP3810807A4 true EP3810807A4 (de) 2022-01-19

Family

ID=68984201

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18923183.0A Pending EP3810807A4 (de) 2018-06-22 2018-06-22 Verfahren und zusammensetzungen für die analyse von krebsbiomarkern

Country Status (4)

Country Link
EP (1) EP3810807A4 (de)
AU (1) AU2018428853A1 (de)
CA (1) CA3103572A1 (de)
WO (1) WO2019245587A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015277059B2 (en) 2014-06-18 2021-06-17 Clear Gene, Inc. Methods, compositions, and devices for rapid analysis of biological markers
AU2016369603A1 (en) 2015-12-18 2018-07-05 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106790A1 (en) * 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106790A1 (en) * 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BELLAHCÈNE A ET AL: "Expression of Bone Sialoprotein, a Bone Matrix Protein, in Human Breast Cancer'", CANCER RESEARCH, 1 June 1994 (1994-06-01), pages 2823 - 2826, XP055871912, Retrieved from the Internet <URL:https://cancerres.aacrjournals.org/content/54/11/2823> [retrieved on 20211212] *
GIUSSANI M ET AL: "Extracellular matrix proteins derived from the tumor microenvironment as circulating breast cancer diagnostic markers", EUROPEAN JOURNAL OF CANCER, vol. 61, 10 July 2016 (2016-07-10), XP029633975, ISSN: 0959-8049, DOI: 10.1016/S0959-8049(16)61137-1 *
See also references of WO2019245587A1 *

Also Published As

Publication number Publication date
EP3810807A1 (de) 2021-04-28
AU2018428853A1 (en) 2021-01-14
WO2019245587A1 (en) 2019-12-26
CA3103572A1 (en) 2019-12-26

Similar Documents

Publication Publication Date Title
EP3707158A4 (de) Krebsbiomarker und verfahren zur verwendung davon
EP3551185A4 (de) Zusammensetzungen und verfahren zur behandlung von cdk4/6-vermitteltem krebs
EP3947715A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs
EP3894392A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3775877A4 (de) Krebsserumbiomarker und verfahren zur verwendung davon
EP3824080A4 (de) Verfahren zur analyse von zellen
EP3612641A4 (de) Zusammensetzungen und verfahren zur bibliothekserstellung und sequenzanalyse
AU2019343184A1 (en) Compositions and methods for treating cancer with anti-CD123 immunotherapy
EP3775290A4 (de) Zusammensetzungen und verfahren zur beurteilung von krebs oder neoplasien
EP3860452A4 (de) Analyseinstrument
EP3773718A4 (de) Zusammensetzungen und verfahren mit anti-nrp2-antikörpern
EP3946470A4 (de) Verbesserte verfahren und zusammensetzungen für synthetische biomarker
EP3863615A4 (de) Verfahren zur behandlung von krebsen mit soliden tumoren unter verwendung von illudinen und biomarkern
EP3594365A4 (de) Biomarker für her2-positiven krebs und anti-her2-therapie und verwendung davon
EP3752194A4 (de) Zusammensetzungen und verfahren für die tumorimmuntherapie
EP3893901A4 (de) Zusammensetzungen und verfahren für immuntherapien
EP3962953A4 (de) Mit krebs assoziierte antikörperzusammensetzungen und verwendungsverfahren
EP3927838A4 (de) Verfahren und zusammensetzungen zur früherkennung von krebs
EP3740590A4 (de) Kits und verfahren zur diagnose von lungenkrebs
EP3698144A4 (de) Zusammensetzungen, verfahren und kits zur diagnose von lungenkrebs
EP3880232A4 (de) Verfahren und zusammensetzungen zur krebsimmuntherapie
EP3938052A4 (de) Verfahren zur vorhersage von prostatakrebs und dessen verwendungen
EP3773585A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3717502A4 (de) Zusammensetzungen und verfahren zur charakterisierung von krebs
EP3854886A4 (de) Verfahren und kits zur bestimmung des krebsrisikos

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20211220

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/6876 20180101ALI20211214BHEP

Ipc: C12Q 1/6883 20180101ALI20211214BHEP

Ipc: C12Q 1/6886 20180101AFI20211214BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230511